These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13693891)

  • 1. The assay of Christmas factor (factor IX) in normal and pathological sera.
    CLARKE JE
    J Med Lab Technol; 1960 Jul; 17():163-76. PubMed ID: 13693891
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on blood coagulation. II. Kinetic study of the interaction between antihemophilic globulin and antithrombin 3 in normal and hemophilic sera.
    Gang NF; Denstedt OF
    Mt Sinai J Med; 1972; 39(5):429-34. PubMed ID: 4538758
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemophilia with a normal blood coagulation time. So-called attenuated atypical hemophilia].
    Fiehrer A
    Bull Acad Natl Med; 1971 Jan 5-12; 155(1):27-30. PubMed ID: 4932854
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of hemophilia with associated deficiency of anti-hemophilic globulin and Christmas factor].
    DINELLI CA; MONTANI E; SALA E
    Rass Clin Sci; 1959 Mar; 35(3):83-5. PubMed ID: 13658425
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihemophilic globulin assay following plasma infusions in hemophilia.
    DOUGLAS AS
    J Lab Clin Med; 1958 Jun; 51(6):850-9. PubMed ID: 13549826
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correction in vitro of A and B hemophilia by various dilutions of normal blood: modifications of clotting time and of prothrombin consumption].
    SOULIER JP; LARRIEU MJ
    Sem Hop; 1954 Aug 26-30; 30(52-53):3033-42. PubMed ID: 13195756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coagulating factors in erythrocytes. III. Activity of a precipitable factor in the hemolysate on hemophilic plasma with platelets removed or in the presence of platelets and on normal plasma with platelets removed].
    TROPEANO L; CACCIOLA E; FERRAUTO A
    Boll Soc Ital Biol Sper; 1958 Oct; 34(19):1179-84. PubMed ID: 13607710
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On certain peculiarities of the blood coagulation system in hemophilia].
    Rutberg RA
    Probl Gematol Pereliv Krovi; 1966 Nov; 11(11):9-15. PubMed ID: 6001927
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preparation of artificial reactive substance permitting determination of antihemophilic B factor (PTC, Christmas factor)].
    WARTELLE O
    Rev Hematol; 1958; 13(1):100-6. PubMed ID: 13555235
    [No Abstract]   [Full Text] [Related]  

  • 11. Modelling the effect of amplification pathway factors on thrombin generation: A comparison of hemophilias.
    Bungay SD
    Transfus Apher Sci; 2008 Feb; 38(1):41-7. PubMed ID: 18294917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the plasma defect in hemophilia.
    JOHNSON SA; SEEGERS WH
    Rev Hematol; 1954; 9(3 bis):529-35. PubMed ID: 14357977
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant?
    Dargaud Y; Bordet JC; Francillon S; NĂ©grier C
    Thromb Haemost; 2007 Apr; 97(4):675-6. PubMed ID: 17393033
    [No Abstract]   [Full Text] [Related]  

  • 14. A theoretical consideration of the blood clotting mechanisms in hemophilia.
    SEEGERS WH
    Schweiz Med Wochenschr; 1954 Jul; 84(29):781-3. PubMed ID: 13195621
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-hemophilic globulin levels in carriers of hemophilia A.
    RAPAPORT SI; PATCH MJ; MOORE FJ
    J Clin Invest; 1960 Nov; 39(11):1619-25. PubMed ID: 13739554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution to the study of Christmas factor deficiency in children].
    FELICI W; BACCHETTA V
    Minerva Pediatr; 1958 Nov; 10(44):1226-34. PubMed ID: 13622441
    [No Abstract]   [Full Text] [Related]  

  • 17. An historical review: the development of laboratory techniques in the study of hemophilia.
    GRACE MG
    Can J Med Technol; 1960 Dec; 22():111-8. PubMed ID: 13707629
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma thromboplastin antecedent and the activation of factor IX.
    DUCKERT F
    Thromb Diath Haemorrh; 1960; 4(Suppl)():145-7. PubMed ID: 13724730
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulating factors in erythrocytes. II. Activity of hemolysates and their derivatives on hemophilic plasma with platelets removed or in the presence of platelets and on normal plasma with platelets removed].
    TROPEANO L; CACCIOLA E; FERRAUTO A
    Boll Soc Ital Biol Sper; 1958 Oct; 34(19):1176-9. PubMed ID: 13607709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.